Le Lézard
Classified in: Health
Subject: MAT

Kalamazoo Valley Adds Medical Cannabis Courses to Its Cannabis Education Program


Expanding on its popular workforce cannabis training program, Kalamazoo Valley Community College today announced that it will offer an online medical cannabis education course.

KALAMAZOO, Mich., Oct. 24, 2022 /PRNewswire-PRWeb/ -- Expanding on its popular workforce cannabis training program, Kalamazoo Valley Community College today announced that it will offer an online medical cannabis education course.

Through a unique partnership with Medical Cannabis Mentor, a leader in online medical cannabis education, Kalamazoo Valley will offer Cannabis Therapeutics 2022, an in-depth, foundational self-paced course for healthcare providers, dispensary personnel and patients. Kalamazoo Valley is Medical Cannabis Mentor's first community college partner.

"Through conversations with community members and patients, we learned there was a lack of formal and easily accessible education for understanding the various therapeutic components of cannabis," said Craig Jbara, vice president for strategic and business development at Kalamazoo Valley. "We believe it is important to promote accurate information and, if appropriate, provide an opportunity for improved quality of life in our community."

The college will begin offering the self-paced, online training starting today, Oct. 24. The certificate program costs $299 and should take between eight to 10 hours to complete.

"There is so much confusion about what medical cannabis is and how to use it," said Medical Cannabis Mentor Founder and CEO Joe Dolce. "That's why our mission is 'Education Before Medication.' The goal is to separate myth from fact and to bring professionals and patients up to speed quickly. Our materials are based on the latest research and data from the world's leading scientists and clinicians."

After the successful completion of the virtual training units, participants will earn a certificate of completion from Kalamazoo Valley Community College and Medical Cannabis Mentors.

Medical Cannabis Mentor online programs are evidence-based and have been vetted and approved by healthcare professions and health agencies, such as New York's Department of Health.

For more information, visit http://www.kvcc.edu/cannabis.

Media Contact

Erin Dominianni, Kalamazoo Valley Community College, 269.488.4445, [email protected]

 

SOURCE Kalamazoo Valley Community College


These press releases may also interest you

at 01:15
Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI: Appointment of Adviser
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
If You Purchased, Paid, or Provided Reimbursement for Some or All of the Price of Branded Lipitor® or its Generic Equivalent, Atorvastatin Calcium, You Could Get Money From a Settlement
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

More news about Health...


News published on and distributed by: